ZURICH, Sept 19 (Reuters) - Swiss drugmaker Novartis
said on Monday that a new analysis showed its Entresto
drug was linked to higher quality of life scores among patients
who had been hospitalized with reduced ejection fraction heart
failure.
Read more
No comments:
Post a Comment